DNA methylation damage: Formation, repair and biological consequences

Chromosomal Alterations: Methods, Results and Importance in Human Health

Volumn 9783540714149, Issue , 2007, Pages 99-121

  Christmann, Markus ^a   Roos, Wynand P ^a   Kaina, Bernd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953292072     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-71414-9_7     Document Type: Chapter

References (127)

1. Aas P. A, Otterlei M, Falnes PO, Vagbo CB, Skorpen F, Akbari M, Sundheim O, Bjoras M, Slupphaug G, Seeberg E et al (2003) Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 421:859-863
2. Abbott PJ, Saffhill R (1979) DNA synthesis with methylated poly (dC-dG) templates. Evidence for a competitive nature to miscoding by O6-methylguanine. Biochim Biophys Acta 562:51-61
3. Armstrong MJ, Galloway SM (1996) Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents. Mutat Res 373:167-178
4. Bartsch H, Montesano R (1984) Relevance of nitrosamines to human cancer. Carcinogenesis 5:1381-1393
5. Becker K, Dosch J, Gregel CM, Martin BA, Kaina B (1996) Targeted expression of human O (6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. Cancer Res 56:3244-3249
6. Becker K, Gregel CM, Kaina B (1997). The DNA repair protein O6-methylguanine-DNA methyltransferase protects against skin tumor formation induced by antineoplastic chloroethylnitrosourea. Cancer Res 57:3335-3338
7. Becker K, Gregel C, Fricke C, Komitowski D, Dosch J, Kaina B (2003) DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors. Carcinogenesis 24:541-546
8. Beranek DT (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 231:11-30
9. Beranek DT, Weis CC, Swenson DH (1980) A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis 1:595-606
10. Blackwell LJ, Bjornson KP, Allen DJ, Modrich P (2001) Distinct MutS DNA-binding modes that are differentially modulated by ATP binding and hydrolysis. J Biol Chem 276:34339-34347
11. Bolzan AD, Bianchi MS (2002) Genotoxicity of streptozotocin. Mutat Res 512:121-134
12. Branch P, Aquilina G, Bignami M, Karran P (1993) Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 362:652-654
13. Brentjens R, Saltz L (2001) Islet cell tumors of the pancreas: the medical oncologist's perspective. Surg Clin North Am 81:527-542
14. Carson DA, Lois A (1995) Cancer progression and p53. Lancet 346:1009-1011
15. Chakravarti D, Ibeanu GC, Tano K, Mitra S (1991) Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase. J Biol Chem 266:15710-15715
16. Chen BJ, Carroll P, Samson L (1994) The Escherichia coli AlkB protein protects human cells against alkylation-induced toxicity. J Bacteriol 176:6255-6261
17. Christmann M, Tomicic MT, Kaina B (2002). Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity. Nucleic Acids Res 30:1959-1966
18. Claij N, te Riele H (2004). Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells. Oncogene 23:260-266
19. Coquerelle T, Dosch J, Kaina B (1995) Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents - a case of imbalanced DNA repair. Mutat Res 336:9-17
20. Day RS III, Ziolkowski C H J, Scudiero DA, Meyer SA, Lubiniecki AS, Girardi AJ, Galloway SM, Bynum GD (1980a) Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature 288:724-727
21. Day RS III, Ziolkowski C H J, Scudiero DA, Meyer SA, Mattern MR (1980b) Human tumor cell strains defective in the repair of alkylation damage. Carcinogenesis 1:21-32
22. DeMarini DM (2004) Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 567:447-474
23. De Weerd-Kastelein EA, Keijzer W, Rainaldi G, Bootsma D (1977) Induction of sister chromatid exchange in Xeroderma pigmentosum cells after exposure to ultraviolet light. Mutat Res 45:253-261
24. Dianov GL, Prasad R, Wilson SH, Bohr VA (1999) Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair. J Biol Chem 274:13741-13743
25. Dinglay S, Trewick SC, Lindahl T, Sedgwick B (2000) Defective processing of methylated singlestranded DNA by E. coli AlkB mutants. Genes Dev 14:2097-2105
26. Dosch J, Christmann M, Kaina B (1998) Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents. Carcinogenesis 19:567-573
27. Duckett DR, Drummond JT, Murchie AI, Reardon JT, Sancar A, Lilley DM, Modrich P (1996) Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d (GpG) adduct. Proc Natl Acad Sci USA 93:6443-6447
28. Dumenco LL, Allay E, Norton K, Gerson SL (1993) The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science 259:219-222
29. Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, Sedgwick B (2002) Reversal of DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci USA 99:16660-16665
30. Dunkern T, Roos W, Kaina B (2003) Apoptosis induced by MNNG in human TK6 lymphoblastoid cells is p53 and Fas/CD95/Apo-1 related. Mutat Res 544:167-172
31. Elder RH, Jansen JG, Weeks RJ, Willington MA, Deans B, Watson AJ, Mynett KJ, Bailey JA, Cooper DP, Rafferty JA et al (1998) Alkylpurine-DNA-N-glycosylase knockout mice show increased susceptibility to induction of mutations by methyl methanesulfonate. Mol Cell Biol 18:5828-5837
32. Falnes PO, Johansen RF, Seeberg E (2002) AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419:178-182
33. Fang WH, Modrich P (1993) Human strand-specific mismatch repair occurs by a bidirectional mechanism similar to that of the bacterial reaction. J Biol Chem 268:11838-11844
34. Fiddler (1975) The occurrence and determination of N-nitroso compounds. Toxicol Appl Pharmacol 31:352-360
35. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038
36. Frosina G, Fortini P, Rossi O, Carrozzino F, Raspaglio G, Cox LS, Lane DP, Abbondandolo A, Dogliotti E (1996) Two pathways for base excision repair in mammalian cells. J Biol Chem 271:9573-9578
37. Galloway SM, Greenwood SK, Hill RB, Bradt CI, Bean CL (1995) A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells. Mutat Res 346:231-245
38. Garcia de Palazzo IE, Adams GP, Sundareshan P, Wong AJ, Testa JR, Bigner DD, Weiner LM (1993) Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res 53:3217-3220
39. Genschel J, Bazemore LR, Modrich P (2002) Human exonuclease I is required for 5' and 3' mismatch repair. J Biol Chem 277:13302-13311
40. Gerson SL (2004) MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4:296-307
41. Glassner BJ, Weeda G, Allan JM, Broekhof JL, Carls NH, Donker I, Engelward BP, Hampson RJ, Hersmus R, Hickman MJ (1999) DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis 14:339-347
42. Goria-Gatti L, Iannone A, Tomasi A, Poli G, Albano E (1992) In vitro and in vivo evidence for the formation of methyl radical from procarbazine: a spin-trapping study. Carcinogenesis 13:799-805
43. Gradia S, Subramanian D, Wilson T, Acharya S, Makhov A, Griffith J, Fishel R (1999) hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol Cell 3:255-261
44. Guengerich FP, Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391-407
45. Hecht SS, Chen CB, Ohmori T, Hoffmann D (1980) Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino) - 1-(3-pyridyl)-1-butanone. Cancer Res 40:298-302
46. Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N, Stupp R (2004) Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10:1871-1874
47. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003
48. Hickman MJ, Samson LD (1999) Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc Natl Acad Sci USA 96:10764-10769
49. Hill DL (1975) Microsomal metabolism of triazenylimidazoles. Cancer Res 35:3106-3110
50. Hirose Y, Katayama M, Stokoe D, Haas-Kogan DA, Berger MS, Pieper RO (2003) The p38 mitogenactivated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNA-methylating agents. Mol Cell Biol 23:8306-8315
51. Hoffman PD, Wang H, Lawrence CW, Iwai S, Hanaoka F, Hays JB (2005) Binding of MutS mismatch repair protein to DNA containing UV photoproducts, "mismatched" opposite Watson-Crick and novel nucleotides, in different DNA sequence contexts. DNA Repair (Amst) 4:983-993
52. Jagerstad M, Skog K (2005) Genotoxicity of heat-processed foods. Mutat Res 574:156-172
53. Kaina B (1985a) The interrelationship between SCE induction, cell survival, mutagenesis, aberration formation and DNA synthesis inhibition in V79 cells treated with N-methyl-N-nitrosourea or N-methyl-N'-nitro-N-nitrosoguanidine. Mutat Res 142:49-54
54. Kaina B (1985b) Secondary lesions and the induction of SCEs and chromosomal aberrations. In: Proceedings of the 13th international congress on biochemistry, Amsterdam, p 31
55. Kaina B (1998) Critical steps in alkylation-induced aberration formation. Mutat Res 404:119-124
56. Kaina B (2004) Mechanisms and consequences of methylating agent-induced SCEs and chromosomal aberrations: a long road traveled and still a far way to go. Cytogenet Genome Res 104:77-86
57. Kaina B, Aurich O (1985) Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction. Mutat Res 149:451-461
58. Kaina B, Fritz G, Mitra S, Coquerelle T (1991) Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis 12:1857-1867
59. Kaina B, Fritz G, Coquerelle T (1993) Contribution of O6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: new insights gained from studies of genetically engineered mammalian cell lines. Environ Mol Mutagen 22:283-292
60. Kaina B, Fritz G, Eschabch E, Preuss I (1995) Transfer of genes affecting resistance of mammalian cells to alkylating drugs - implication for cancer chemotherapy. In: Zeller WJ, Eisenbrand G, Hellmann K (eds) Reduction of anticancer drug toxicity. Pharmacological, biologic and gene therapeutic approaches. Karger, Basel, pp 125-141
61. Kaina B, Ziouta A, Ochs K, Coquerelle T (1997) Chromosomal instability, reproductive cell death and apoptosis induced by O6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: facts and models. Mutat Res 381:227-241
62. Kamataki T, Nunoya K, Sakai Y, Kushida H, Fujita K (1999) Genetic polymorphism of CYP2A6 in relation to cancer. Mutat Res 428:125-130
63. Karran P, Bignami M (1994) DNA damage tolerance, mismatch repair and genome instability. BioEssays 16:833-839
64. Klungland A, Lindahl T (1997) Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNaseIV (FEN1). EMBO J 16:3341-3348
65. Kurowski MA, Bhagwat AS, Papaj G, Bujnicki JM (2003) Phylogenomic identification of five new human homologs of the DNA repair enzyme AlkB. BMC Genomics 4:48
66. Lai DY, Arcos JC (1980) Minireview: dialkylnitrosamine bioactivation and carcinogenesis. Life Sci 27:2149-2165
67. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M et al (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225
68. Lees NP, Harrison KL, Hall CN, Margison GP, Povey AC (2004) Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC→AT transition mutations in a population exposed to methylating agents. Carcinogenesis 25:1243-1247
69. Lehman AR (2002) Replication of damaged DNA in mammalian cells: new solutions to an old problem. Mutat Res 509:23-34
70. Li GM, Modrich P (1995) Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl Acad Sci USA 92:1950-1954
71. Li GM, Wang H, Romano LJ (1996) Human MutSalpha specifically binds to DNA containing aminofluorene and acetylaminofluorene adducts. J Biol Chem 271:24084-24088
72. Lin HL, Parsels LA, Maybaum J, Hollenberg PF (1999) N-Nitrosodimethylamine-mediated cytotoxicity in a cell line expressing P450 2E1: evidence for apoptotic cell death. Toxicol Appl Pharmacol 157:117-124
73. Longley MJ, Pierce AJ, Modrich P (1997) DNA polymerase delta is required for human mismatch repair in vitro. J Biol Chem 272:10917-10921
74. Margison GP, Povey AC, Kaina B, Santibanez Koref MF (2003) Variability and regulation of O6-alkylguanine-DNA alkyltransferase. Carcinogenesis 24:625-635
75. Marnett LJ, Burcham PC (1993) Endogenous DNA adducts: potential and paradox. Chem Res Toxicol 6:771-785
76. Matsumoto Y, Kim K (1995) Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science 269:699-702
77. Matsumoto Y, Kim K, Hurwitz J, Gary R, Levin DS, Tomkinson AE, Park MS (1999) Reconstitution of proliferating cell nuclear antigen-dependent repair of apurinic/apyrimidinic sites with purified human proteins. J Biol Chem 274:33703-33708
78. Meikrantz W, Bergom MA, Memisoglu A, Samson L (1998) O6-Alkylguanine DNA lesions trigger apoptosis. Carcinogenesis 19:369-372
79. Mitacek EJ, Brunnemann KD, Hoffmann D, Limsila T, Suttajit M, Martin N, Caplan LS (1999) Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand. Carcinogenesis 20:133-137
80. Modrich P, Lahue R (1996) Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 65:101-133
81. Nakamura J, La DK, Swenberg JA (2000) 5'-nicked apurinic/apyrimidinic sites are resistant to beta-elimination by beta-polymerase and are persistent in human cultured cells after oxidative stress. J Biol Chem 275:5323-5328
82. Nakatsuru Y, Matsukuma S, Nemoto N, Sugano H, Sekiguchi M, Ishikawa T (1993) O6-Methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc Natl Acd Sci USA 90:6468-6472
83. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C (1997) Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 23:35-61
84. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM et al (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80
85. O'Connor TR (1993) Purification and characterization of human 3-methyladenine-DNA glycosylase. Nucleic Acids Res 21:5561-5569
86. Ochs K, Kaina, B. (2000) Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res 60:5815-5824
87. Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, Stupp R (2004) Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10:3728-3736
88. Palombo F, Gallinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo A, Truong O, Hsuan JJ, Jiricny J (1995) GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 268:1912-1914
89. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD et al (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629
90. Pegg AE, Dolan ME, Moschel RC (1995) Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 51:167-223
91. Pepponi R, Marra G, Fuggetta MP, Falcinelli S, Pagani E, Bonmassar E, Jiricny J, D'Atri S (2003) The effect of O6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1, 3-bis (2-chloroethyl) 1-nitrosourea, and cisplatin. J Pharmacol Exp Ther 304:661-668
92. Peto R, Gray R, Brantom P, Grasso P (1984) Nitrosamine carcinogenesis in 5120 rodents: chronic administration of sixteen different concentrations of NDEA, NDMA, NPYR and NPIP in the water of 4440 inbred rats, with parallel studies on NDEA alone of the effect of age of starting (3, 6 or 20 weeks) and of species (rats, mice or hamsters). IARC Sci Publ 627-665
93. Prasad R, Beard WA, Strauss PR, Wilson SH (1998) Human DNA polymerase beta deoxyribose phosphate lyase. Substrate specificity and catalytic mechanism. J Biol Chem 273:15263-15270
94. Qian X, von Wronski MA, Brent TP (1995) Localization of methylation sites in the human O6-methylguanine-DNA methyltransferase promoter: correlation with gene suppression. Cacinogenesis 16:1385-1390
95. Qin X, Zhou H, Liu L, Gerson SL (1999) Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Carcinogenesis 20:1667-1673
96. Rasouli-Nia A, Sibghat-Ullah, Mirzayans R, Paterson MC, Day RS III (1994) On the quantitative relationship between O6-methylguanine residues in genomic DNA and production of sister-chromatid exchanges, mutations and lethal events in a Mer-human tumor cell line. Mutat Res 314:99-113
97. Reid JM, Kuffel MJ, Miller JK, Rios R, Ames MM (1999) Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1. Clin Cancer Res 5:2192-2197
98. Ringvoll J, Nordstrand LM, Vagbo CB, Talstad V, Reite K, Aas PA, Lauritzen KH, Liabakk NB, Bjork A, Doughty RW et al (2006) Repair deficient mice reveal mABH2 as the primary oxidative demethylase for repairing 1meA and 3meC lesions in DNA. EMBO J 25:2189-2198
99. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M (1988) Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 48:161-164
100. Roos W, Baumgartner M, Kaina B (2004) Apoptosis triggered by DNA damage O6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas/CD95/-Apo-1. Oncogene 23:359-367
101. Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, Kaina B (2007) Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O (6)-methylguanine. Oncogene 26:186-197
102. Sedgwick B, Lindahl T (2002) Recent progress on the Ada response for inducible repair of DNA alkylation damage. Oncogene 21:8886-8894
103. Sibghat-Ullah L, Day RS III, Dobler KD, Paterson MC (2001) Initiation of strand incision at G: T and O6-methylguanine: T base mismatches in DNA by human cell extracts. Nucleic Acids Res 29:2409-2417
104. Skibba JL, Beal DD, Ramirez G, Bryan GT (1970) N-demethylation the antineoplastic agent4 (5) - (3, 3-dimethyl-1-triazeno) imidazole-5 (4)-carboxamide by rats and man. Cancer Res 30:147-150
105. Sklar RM, Strauss B (1981) Removal of O6-methylguanine from DNA of normal and xeroderma pigmentosum-derived lymphoblastoid lines. Nature 289:417-420
106. Sobol RW, Wilson SH (2001) Mammalian DNA beta-polymerase in base excision repair of alkylation damage. Prog Nucleic Acid Res Mol Biol 68:57-74
107. Sobol RW, Prasad R, Evenski A, Baker A, Yang XP, Horton JK, Wilson SH (2000) The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity. Nature 405:807-810
108. Stojic L, Mojas N, Cejka P, Di Pietro M, Ferrari S, Marra G, Jiricny J (2004) Mismatch repairdependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev 18:1331-1344
109. Stucki M, Pascucci B, Parlanti E, Fortini P, Wilson SH, Hubscher U, Dogliotti E (1998) Mammalian base excision repair by DNA polymerases delta and epsilon. Oncogene 17:835-843
110. Tominaga Y, Tsuzuki T, Shiraishi A, Kawate H, Sekiguchi M (1997) Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting. Carcinogenesis 18:889-896
111. Toorchen D, Topal MD (1983) Mechanisms of chemical mutagenesis and carcinogenesis: effects on DNA replication of methylation at the O6-guanine position of dGTP. Carcinogenesis 4:1591-1597
112. Toyooka S, Toyooka KO, Maruyama R, Virmani AK, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T. Sugio K et al (2001) DNA methylation profiles of lung tumors. Mol Cancer Ther 1:61-67
113. Trewick SC, Henshaw TF, Hausinger RP, Lindahl T, Sedgwick B (2002) Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature 419:174-178
114. Tsuzuki T, Sakumi K, Shiraishi A, Kawate H, Igarashi H, Iwakuma T, Tominaga Y, Zhang S, Shimizu S, Ishikawa T et al. (1996) Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis 17:1215-1220
115. Umar A, Kunkel TA (1996) DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 238:297-307
116. van Zeeland AA, Mohn GR, Aaron CS, Glickman BW, Brendel M, de Serres FJ, Hung CY, Brockman HE (1983) Molecular dosimetry of the chemical mutagen ethyl methanesulfonate. Quantitative comparison of the mutagenic potency in Neurospora crassa and Saccharomyces cerevisiae. Mutat Res 119:45-54
117. Vogel E, Natarajan AT (1979) The relation between reaction kinetics and mutagenic action of mono-functional alkylating agents in higher eukaryotic systems. I. Recessive lethal mutations and translocations in Drosophila. Mutat Res 62:51-100
118. Walker R (1990) Nitrates, nitrites and N-nitrosocompounds: a review of the occurrence in food and diet and the toxicological implications. Food Addit Contam 7:717-768
119. Wang Y, Qin J (2003) MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc Natl Acad Sci USA 100:15387-15392
120. Wang Z, Gleichmann H (1998) GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47:50-56
121. Wilson DM, Barsky D (2001) The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat Res 485:283-307
122. Wogan GN, Tannenbaum SR (1975) Environmental N-nitroso compounds: implications for public health. Toxicol Appl Pharmacol 31:375-383
123. Wojcik A, Bruckmann E, Obe G (2004) Insights into the mechanisms of sister chromatid exchange formation. Cytogent Genome Res 104:301-309
124. Xu YH, Richert N, Ito S, Merlino GT, Pastan I (1984) Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 81:7308-7312
125. Yarosh DB, Foote RS, Mitra S, Day RS 3rd (1983) Repair of O6-methylguanine in DNA by demethylation is lacking in Mer-human tumor cell strains. Carcinogenesis 4:199-205
126. Yoshioka K, Yoshioka Y, Hsieh P (2006) ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol Cell 22:501-510
127. Zhou ZQ, Manguino D, Kewitt K, Intano GW, McMahan CA, Herbert DC, Hanes M, Reddick R, Ikeno Y, Walter CA (2001) Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6-methylguanine-DNA methyltransferase. Proc Natl Acad Sci USA 98:12566-12571